当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析

冠昊生物

(300238)

  

流通市值:40.72亿  总市值:40.73亿
流通股本:2.65亿   总股本:2.65亿

冠昊生物(300238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年年度实现净利润0.15亿元,每股收益0.09元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年年度最新股东权益48781.69万元,未分配利润-29757.94万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年年度最新总资产80653.24万元,负债31871.55万元。

利润表
报告期2025-12-312025-09-302025-06-302025-03-31
营业总收入387,749,767.9293,480,433.06200,869,647.9894,797,135.39
营业总成本358,622,829.07261,309,394.44176,257,580.5576,040,276.86
其他经营收益
营业利润30,453,513.1531,441,561.0223,980,044.8417,848,423.42
利润总额27,280,561.8332,119,529.5224,785,692.0419,106,612.73
净利润14,787,270.0420,429,167.5316,512,890.1714,727,786.55
每股收益
其他综合收益-125,555.44-69,791.15-75,889.46-16,948.91
综合收益总额14,661,714.620,359,376.3816,437,000.7114,710,837.64
资产负债表
报告期2025-12-312025-09-302025-06-302025-03-31
流动资产:
流动资产合计325,608,234.99300,732,354.2304,563,094.8282,432,258.91
非流动资产:
非流动资产合计480,924,177.2473,774,578.98478,205,473.28481,810,551.95
资产总计806,532,412.19774,506,933.18782,768,568.08764,242,810.86
流动负债:
流动负债合计188,540,549.12152,297,698.75164,814,764.13145,955,381.56
非流动负债:
非流动负债合计130,174,936.54128,716,346.25128,034,531.24129,973,588.16
负债合计318,715,485.66281,014,045292,849,295.37275,928,969.72
所有者权益(或股东权益):
归属于母公司股东权益合计570,067,516.98572,121,327.51565,800,826.75557,207,253
股东权益合计487,816,926.53493,492,888.18489,919,272.71488,313,841.14
负债和股东权益合计806,532,412.19774,506,933.18782,768,568.08764,242,810.86
现金流量表
报告期2025-12-312025-09-302025-06-302025-03-31
经营活动产生的现金流量:
经营活动现金流入小计456,130,353.59337,580,752.35220,818,693.53107,890,735.24
经营活动现金流出小计384,656,557.83284,944,912.18181,539,565.2892,819,977.44
经营活动产生的现金流量净额71,473,795.7652,635,840.1739,279,128.2515,070,757.8
投资活动产生的现金流量:
投资活动现金流入小计3,177,691.3427,914.3527,914.3524,119.35
投资活动现金流出小计39,368,477.3330,788,916.9325,434,157.2624,933,790.43
投资活动产生的现金流量净额-36,190,785.99-30,761,002.58-25,406,242.91-24,909,671.08
筹资活动产生的现金流量:
筹资活动现金流入小计51,114,80042,051,30030,101,30030,101,300
筹资活动现金流出小计30,096,410.4426,871,520.767,393,425.022,865,911.69
筹资活动产生的现金流量净额21,018,389.5615,179,779.2422,707,874.9827,235,388.31
汇率变动对现金及现金等价物的影响-182,486.94-103,782.15-113,482.72-25,515.77
现金及现金等价物净增加额56,118,912.3936,950,834.6836,467,277.617,370,959.26
期末现金及现金等价物余额160,602,712.5141,434,634.79140,951,077.71121,854,759.37
补充资料:
现金及现金等价物的净增加额56,118,912.39-36,467,277.6-
TOP↑